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For decades, the United States has relied on the criminal system to respond to substance use 
disorder — with minimal success.1 Shortly before the publication of this guide, the Centers for 
Disease Control and Prevention announced that over 93,000 people lost their lives to drug 
overdoses in the United States in 2020, an increase of nearly 30 percent from the previous year.2 
These staggering figures illustrate the urgent need for criminal system actors, and prosecutors 
in particular, to rethink their roles in one of America’s most intractable public health crises. 
Laws, policies, and practices have provided prosecutors with immense power over how 
communities respond to the intersections of drug use, poverty, racial inequities, and public 
safety. Each day, prosecutors make choices that bear directly on the rights, health, and livelihood 
of people who use drugs. However, many prosecutors lack full awareness of how their policies 
and everyday actions can imperil the health and safety of the communities they are bound to 
protect.  
Between 1980 and 2016, drug-related arrests increased by 171 percent and now account for 
more than 1.5 million arrests annually — mostly for drug possession.3 Today, about one in five 
incarcerated people are jailed or imprisoned for a drug offense.4 Each year, the United States 
spends more than $47 billion on drug prohibition.5 
Our nation’s reliance on policing and prosecution has failed to achieve many of its purported 
goals of reducing the supply, demand, and markets for illicit drugs on a meaningful scale. As 
enforcers of our nation’s drug laws, prosecutors too often use their power to keep the engine 
turning for mass incarceration, which has taken a grave and inequitable toll on the vitality 
of many communities — especially those of color. Yet, with robust enforcement powers and 
political influence, prosecutors have a unique opportunity to improve our society’s response to 
drug use while minimizing the harms of the legal system.  
This document seeks to provide prosecutors with a set of guiding principles and strategies 
for advancing drug policy grounded in principles of harm reduction, public health, and racial 
justice. These recommendations convey ideas informed by best practices, empirical evidence, 
1 See Redonna K. Chandler et al., Treating Drug Abuse and Addiction in the Criminal Justice System: Improving 
Public Health and Safety, 301 JAMA 183-90 (2009) (“The past 20 years have seen significant increases in the 
numbers of individuals incarcerated or under other forms of criminal justice supervision in the United States. These 
numbers are staggering—approximately 7.1 million adults in the United States are under some form of criminal 
justice supervision . . . . An estimated one-half of all prisoners (including some sentenced for other than drug 
offenses) meet the criteria for diagnosis of drug abuse or dependence.”)). 
2 Josh Katz & Margot Sanger-Katz, Drug Deaths Spiked by 30 Percent Last Year, Surpassing 90,000, N.Y. Times (Jul. 
14, 2021). 
3 Rebecca Neusteter & Megan O’Toole, Every Three Seconds, Unlocking Prison Data on Arrests: Emerging Findings 
Vera Inst. of Just. (Jan. 2019). 
4 Wendy Sawyer & Peter Wagner, Mass Incarceration: The Whole Pie 2020, Prison Pol’y Initiative (Mar. 24, 2020). 
5 Jeffrey Miron, CATO Inst., The Budgetary Effects of Ending Drug Prohibition, Tax & Budget Bull. No. 83 (July 23, 
2018). 
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and the collective wisdom of a working group of prosecutors, defense attorneys, advocates, 
people who have personally experienced incarceration for drug-related crimes, and public 
health experts from diverse jurisdictions. This Guide’s central goal is to provide practical advice 
to prosecutors on how they can use their discretion on a daily basis in a way that promotes public 
health. Our hope is that this resource, along with corresponding short video presentations, will 
stimulate creativity among prosecutors and inspire them to chart a more promising course of 
U.S. drug policy. 
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Vision Statement & Guiding Principles 
This guide was created following a six-month convening of experts in prosecution, public health, 
and harm reduction. It envisions a path forward for prosecutors handling cases involving the 
use and sale of drugs. The following are the working group’s guiding principles:
1. Traditional prosecution of drug-related crimes, with an emphasis on incarceration, is 
largely ineffective.6 Instead, prosecutors should adopt a range of practical strategies 
to achieve two interrelated goals: (1) enhancing access to voluntary treatment and 
services in community settings; and (2) minimizing the role of the criminal system to 
mitigate harms created by arrest, incarceration, surveillance, involuntary treatment, and 
the stigma of a criminal record. 
2. Prosecutors must acknowledge that a complex interplay of social, economic, and 
political inequities underlie drug use, substance use disorder, and drug markets in 
underserved communities. Prosecutors should learn and reckon with the ways in which 
the laws, policies, and practices of the “War on Drugs” are inextricably tied to the 
historical legacies of racial discrimination and oppression.  
3. The health and well-being of people who use drugs should guide prosecutorial policies 
and practice. All policies and strategies implemented along the criminal legal continuum 
should be assessed by outcomes related to health equity, social stability, and racial 
justice, rather than solely punishment and recidivism.7   
    
4. Prosecutors should implement policy changes that are sustainable, in that they endure 
changes in leadership and decreased resources during economic downturns. 
5. Prosecutors should employ a humanistic approach to their work by evaluating each 
case based on all of the circumstances, rather than by the crime charged.
6  More Imprisonment Does Not Reduce State Drug Problems, Pew Charitable Trusts (Mar. 8, 2018). 
7 David Noble, Mapping the Landscape of Prosecutor-Led Pretrial Diversion, 11 Crim. L. Prac. 8, 10 (2020) 
(“Traditionally, prosecutors and other stakeholders have gauged the success or failure of diversion based on 
the rate of recidivism among participants. This is problematic, in part because it is extremely difficult to draw a 
causal link between a diversion model’s offerings and whether or not a participant is rearrested. Further, recidivism 
cannot properly account for the progress an individual makes towards strengthening familial and communal ties, 
furthering their education, or improving their employment prospects.”). 
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Action Guide for Working Within the 
Criminal System
This guide gives examples of how prosecutors can realize the goals of harm reduction, health 
promotion, and racial justice.
I. Education for Prosecutors 
It is imperative that both line and elected prosecutors have a basic understanding of the 
physical effects of substance use disorder, what leads people to use and sell drugs, the nature 
of recurring use, and the medical treatment options for substance use disorder. Without a solid 
understanding of these topics, prosecutors cannot make the best decisions or most appropriate 
plea offers in drug-related cases. Additionally, elected prosecutors should provide their staff 
with opportunities to learn about the history of drug laws in the United States. It is critical that 
all prosecutors understand the legacy of racially motivated drug laws and enforcement tactics 
so that they can work to actively combat racism in the criminal system. 
As a starting point, elected prosecutors should invite directly impacted people to speak to their 
staff about their experiences with drug use, diversion programs, and incarceration resulting 
from drug-related offenses. These presentations can humanize accused people for prosecutors 
and teach prosecutors about the realities of substance use disorder, the recurrence of use, or 
why some people turn to drug trafficking for income.
Elected prosecutors should also bring in medical professionals and harm reduction experts 
to explain to staff members the basics of substance use disorder and the importance of 
responding to recurrence of use with compassion. Local harm reduction leaders can explain 
the foundations of harm reduction, the consequences of punitive drug law enforcement, and 
the different types of interventions and support services shown to deliver the best outcomes. 
Click here for short video presentations by Andre Ward, 
Julie Eldred and Tele Rabii, who have all been directly 
impacted by the criminal system.
Click here for a short video presentation by harm reduction 
experts Ronald Martin and Robert Childs.
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Offices with limited resources that cannot bring in speakers must, at a minimum, require staff 
to read materials so they can familiarize themselves with these issues. Refer to the attached 
Appendix for resources all staff members can read to educate themselves on these topics. 
Elected prosecutors should develop an internal communication strategy for their staff that 
outlines available alternatives to incarceration programs in their jurisdiction. Ideally, offices will 
also provide structural tools that assist their staff in making those referrals, such as a flowchart 
to help prosecutors identify cases that are eligible for diversion or other non-incarceratory 
programs. That way, line prosecutors can effectively utilize alternatives to incarceration in their 
communities when appropriate.
II. Before an Arrest: Culture Change, Legislative Advocacy, and Partnering with 
Pre-Arrest Diversion and Prevention Programs 
The pursuit of public health and public safety are not mutually exclusive goals. There are 
structural deficiencies in our state and local infrastructures for providing people with services 
to treat substance use disorder. The scarcity of compassionate support and evidence-based 
services for people who use drugs is most pronounced in over-policed communities where 
most residents are racial minorities or are economically disadvantaged.8
While prosecutors should try to mitigate the harms that arise from the criminal system, they 
should also work to reduce the role of law enforcement in addressing drug use altogether. 
First, prosecutors should change the narrative around drugs in the community by emphasizing 
treatment and support rather than traditional, punitive responses to drug offenses. Second, 
prosecutors should advocate for social services for people with substance use disorders. 
Prosecutors can leverage their platform to support other community leaders seeking to expand 
the capacity of drug treatment, supportive housing, and other services in their communities that 
minimize the role of the criminal system. Third, prosecutors should advocate for legislation that 
adopts a public health approach to drug policy. Fourth, prosecutors should support effective 
existing pre-arrest diversion programs. Finally, prosecutors should engage their communities 
when developing new pre-arrest diversion programs. Each of these recommendations is 
discussed in more detail below. 
8 See Janet R. Cummings et al., Decline in Public Substance Use Disorder Treatment Centers Most Serious in 
Counties with High Shares of Black Residents, Health Affairs Vol. 35, 6 (2016) (“By 2010, counties with a very high or 
extremely high percentage of black residents were significantly less likely to have any outpatient facility, compared 
to counties with less than the mean percentage of black residents in the multivariate analysis . . . .”).
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Click here for a short video presentation featuring three 
prosecutors working to change drug policy within their 
respective offices.
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A. Change the Narrative on Drugs – Both in the Prosecutor’s Office and in the Community 
As stewards of public safety, elected prosecutors have a powerful influence over how the 
public views drug use and drug-related crimes. An arrest, conviction, or incarceration for 
a drug-related offense creates stigma for the accused. Stigma involves social disapproval, 
shame, and discrimination based on one’s association with a particular group or identity.9 
Research shows that feeling stigmatized makes people less likely to seek help or services 
from health care providers, treatment centers, and other community members.10 Stigma 
and criminalization create significant barriers to gaining community support for drug 
treatment and harm reduction services that are vital to slowing the wave of overdose deaths.  
 
Drug laws in the United States grant prosecutors immense power over the lives of people 
who encounter the criminal system. Prosecutors should use this power to uproot and reverse 
an ideology that labels people who use and sell drugs as criminals who always deserve 
punishment. As more prosecutors have begun to acknowledge that this narrative is one 
that contributes to, rather than effectively addresses the public health crisis, prosecutors 
at all levels of experience can play an instrumental role in de-stigmatizing drug use. For 
example, line prosecutors who have a personal connection to these issues and understand 
the science of substance use disorder can raise awareness among their colleagues and 
advocate for community-driven solutions over punishment. Those handling drug cases 
who do not have such experience should make it a priority to educate themselves about 
substance use disorder and ways to more humanely address their drug-related cases. 
 
Elected prosecutors should promote a narrative in their community that calls for 
downsizing the role of the criminal system when it comes to drug-related issues, while 
increasing resources for public health solutions to substance use disorder. Elected 
prosecutors should organize visits with their line prosecutors to local methadone 
clinics and other harm reduction-oriented facilities. During such a visit, prosecutors 
should strive to learn from harm reduction service providers the importance of 
“meeting people where they are” to earn their trust and reduce the stigma that may 
stand in the way of accessing services.  They should also seek to learn how fear of 
arrest and prosecution can interrupt or interfere with utilization of these vital services.  
 
9  See John F. Kelly et al., Stop Talking ‘Dirty’: Clinicians, Language, and Quality of Care for the Leading Cause of 
Preventable Death in the United States, 128 Am. J. of Med. 1, 8-9 (Sept. 2, 2014) (“Stigma is defined as an attribute, 
behavior, or condition that is socially discrediting.”). 
10 Id. (“[Stigma] is important because of the 23 million Americans who meet criteria for a substance use disorder 
each year, only 10% access treatment, and stigma is a major barrier to seeking help.”). 
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Click here for a short video presentation by harm reduction 
experts Ronald Martin and Robert Childs.
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Additionally, prosecutors’ offices can promote a culture shift inside and outside the 
office by avoiding stigmatizing language when discussing drug-related offenses. 
Prosecutors should take every opportunity to use language that humanizes 
people involved with the criminal system by avoiding words like “addict,” and 
instead saying “a person with substance use disorder.” For additional resources 
on the importance of humanizing language, refer to the attached Appendix. 
 
In addition, prosecutors should help promote access to opioid agonist medications 
(e.g. methadone and buprenorphine), which do not require full detoxification 
before use, unlike extended release naltrexone (Vivitrol).11 Prosecutors should be 
aware of the stigma that people who choose to use opioid agonists frequently 
endure in both the justice and health care systems. Prosecutors can help mitigate 
stigma by promoting access to all FDA-approved medications for opioid use 
disorders, and ensuring that people have autonomy to choose which medication 









Finally, prosecutors should advocate for the end of urine drug screening as a basis 
for sanctions in the criminal system. Drug testing is frequently used at various stages 
of the legal process and is commonly imposed as a condition of pleas, probation, or 
parole. Using drug testing as a condition of release and as a punitive tool, rather than 
as an aid for treatment, is harmful in several ways.12 First, it promotes an abstinence-only 
approach to substance use disorder. It therefore fails to consider the fact that people 
with substance use disorder and contact with the criminal system often return to use, 
11 Joshua D. Lee et al., Comparative Effectiveness of Extended-Release Naltrexone Versus Buprenorphine-Naloxone 
for Opioid Relapse Prevention, 391 Lancet 309 (2017) (“In summary, for the intention-to-treat population, XR-NTX 
[extended release naltrexone] treatment was less effective than BUP-NX [sublingual buprenorphine-naloxone] 
treatment for the prevention of opioid relapse following admission for inpatient detoxification. This outcome was 
primarily due to fewer XR-NTX inductions and high occurrence of relapse among induction failures.”). See also 
Mark A. Schuckit, Treatment of Opioid Use Disorders, 375 N. Engl. J. Med. 357 (2016) (“[I]n most studies of oral 
naltrexone, approximately 50% of patients discontinued the drug by 6 weeks, with only 15% remaining in the 
study at 25 weeks in some evaluations. Higher rates of adherence are seen with opioid maintenance…. In addition, 
because of the loss of tolerance that occurs with abstinence from opioids, the danger of overdoses that may lead 
to death is enhanced among patients who discontinue naltrexone and return to opioid use.”). 
12 See Matthew Hurford, et. al., Appropriate Use of Drug Testing in Clinical Addiction Medicine, Am. Soc’y of 
Addiction Med. 2, 5 (April 5, 2017) (“The inappropriate use of drug testing can have extraordinary costs to third-
party payers, taxpayers, and at times the patients who are receiving care . . . . Drug testing should be used as a tool 
for supporting recovery rather than exacting punishment.”).                 
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Campopiano, a medical professional, on the different 
medications used to treat opioid use disorder.  
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and that substance use disorder is a chronic, relapsing condition.13 Punishing people 
with a conviction or incarceration for a positive drug test is counterproductive. This is 
particularly true for community members recently released from prison who are likely to 
return to use and face the added stigma of a criminal record.14  It should also be noted 
that drug testing poses financial and logistical hurdles for those under court supervision.15  
 
In addition, when drug testing is a condition of release, people with substance use disorder may 
face re-incarceration for using drugs. Nearly one in four people are in prison for supervision 
violations.16 Strict drug testing conditions may discourage those with substance use disorder 
to seek help when they need it most, fearing additional criminal charges or incarceration. 
In some situations, drug testing may be helpful to ensure the safety of the individual or the 
community. For example, some people who struggle with substance use may view drug 
testing as a way to measure their own progress in treatment. Additionally, in cases where 
an individual’s substance use has resulted in harm to their community, it may be beneficial 
to drug test the individual for reasons of public safety (an example would be a person who 
burglarized a home to steal money to buy drugs). However, drug testing should always be 
trauma-informed and should never be used to “catch” someone in the act of consuming 
drugs in order to punish them more severely.
13 Barbara Andraka-Christou, Improving Drug Courts Through Medication-Assisted Treatment for Addiction, 23 Va. 
J. Soc. Pol’y & L. 179, 221 (2016) (“One-third of individuals incarcerated for drug-related crimes relapse within 2 
months of release; 80% relapse within one year; and 95% relapse within 3 years. Additionally, studies have found 
that rates of treatment contact post-prison are low, and that the chance of relapse is especially high immediately 
following release.”); The Science of Drug Use and Addiction: The Basics, Nat’l Inst. on Drug Abuse (last visited Sept. 
6, 2021) (“The chronic nature of addiction means that relapsing to drug use is not only possible but also likely. 
Relapse rates are similar to those for other well-characterized chronic medical illnesses such as hypertension and 
asthma, which also have both physiological and behavioral components.”). 
14 Chandler et al., supra note 1 (“On release from prison or jail, addicted persons will experience challenges to 
their sobriety through multiple stressors that increase their risk of relapsing to drug use. These include the stigma 
associated with being labeled an ex-offender, the need for housing and legitimate employment, stresses in re-
unifying with family, and multiple requirements for criminal justice supervision.”). 
15 Putting an End to Drug Testing, Drug Pol’y Alliance (April 1, 2021) (“Drug tests can cost individuals up to $60 out-
of-pocket. Often, people are notified that they must immediately report for a drug test, requiring them to make the 
difficult choice of whether or not to drop all family and job obligations to report for a test, sometimes dozens of 
miles away.” (citing How Court-Ordered Drug Testing Poses Impossible Choices, PBS News Hour (Dec. 8, 2020)). 
16 Confined and Costly: How Supervision Violations Are Filling Prisons and Burdening Budgets, Council of State 
Gov’ts Just. Ctr. (June 18, 2019). 
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impact of drug testing when he participated in drug court.
A New Approach: A Prosecutor’s Guide to Advancing a Public Health Response to Drug Use
B. Advocate for Social Services for People With Substance Use Disorder
Due to society’s reliance on imprisonment to address substance use disorder, access to 
public health services is often limited. Prosecutors can build support for proposals to 
address gaps in a community’s social service infrastructure. For example, prosecutors can 
back efforts to create or expand public health interventions and services that protect the 
health and safety of people who use drugs. Examples of interventions shown to promote 
health include: syringe-service programs,17 medications for opioid use disorder (MOUD),18 
naloxone distribution programs,19 safe injection and overdose prevention sites,20 and 
supportive and permanent housing programs. Access to these programs is limited or 
non-existent in many communities due to legal restrictions, lack of health insurance, and 
insufficient investments from state and local governments.21 An elected prosecutor who 
removes the stigma from these services by vocally supporting them can greatly impact a 
community’s willingness to invest in them.
C. Advocate for Legislative Change
Elected prosecutors should work collaboratively with lawmakers and other community 
stakeholders to support legislation that adopts a public health approach to drug policy. 
17 The Centers for Disease Control and Prevention (CDC) describes syringe-service programs as “a public health 
strategy for persons who inject drugs (PWID) . . . . [that] aim to reduce PWID’s risk of getting and transmitting HIV, 
viral hepatitis, and other blood-borne infections by using new or sterile injection equipment for each injection.”  
18 According to the CDC, medications for opioid use disorder (MOUD) include methadone, buprenorphine, and 
naltrexone. These are prescription medications that can help prevent withdrawal symptoms or block the effects of 
opioids. 
19 Naloxone distribution programs give community members access to naloxone, a medication used to reverse an 
opioid overdose. Expanding Access to Naloxone: A Review of Distribution Strategies, Penn Leonard Inst. of Health 
Econ. & CHERISH Issue Brief (May 29, 2019). 
20 Safe injection sites (also called safe or supervised injection facilities, drug consumption rooms, and overdose 
prevention sites or centers) are places where people can use drugs with sterile equipment, under the supervision 
of trained staff who are equipped to respond to overdose events and other medical emergencies. Safe injection 
sites are not currently available in the United States, though they are available in Canada and in some European 
nations. When tailored to the needs of a community, these services have been shown to reduce unsafe disposal of 
used equipment, prevent overdoses, and reduce drug use in public spaces. See Alex H. Kral & Peter J. Davidson, 
Addressing the Nation’s Opioid Epidemic: Lessons from an Unsanctioned Supervised Injection Site in the U.S., 53 
Am. J. Preventative Med. 919, 919-20 (2017); M-J. S. Milloy, et al., Estimated Drug Overdose Deaths Averted by 
North America’s First Medically-Supervised Safer Injection Facility, 3 PLOS ONE (2008). 
21 See Solmaz Amiri et al., Disparities in Access to Opioid Treatment Programs and Office-Based Buprenorphine 
Treatment Across the Rural-Urban and Area Deprivation Continua: A U.S. Nationwide Small Area Analysis, 24 
Value in Health 188, 193 (2020) (discussing the limited access to opioid treatment programs and office-based 
buprenorphine treatment); Amanda J. Abraham et al., Geographic Disparities in Availability of Opioid Use Disorder 
Treatment for Medicaid Enrollees, 53 Health Servs. Res. 389, 400-401 (2017) (concluding that “Medicaid enrollees in 
areas in the Southeast have the largest gaps between county-level OUD [opioid use disorder] rates and estimated 
county-level capacity for treatment, as measured by county-level total treatment admissions among OTPs [opioid 
treatment programs] that accept Medicaid.”). 
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Attorney Sherry Boston (DeKalb County, Georgia) discuss 
legislative advocacy. 
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Recently, several jurisdictions have decriminalized possession of drug paraphernalia.22 
Additionally, state legislators in Washington, Kansas, New York, Maryland, Massachusetts, 
Rhode Island, Vermont, and Maine have introduced bills decriminalizing possession of 
small amounts of controlled substances.23 Prosecutors should support efforts to undo 
harmful drug laws by supporting public health-focused legislation. Below is a list of 
examples of prosecutors publicly advocating for changes in legislation to promote a 
public health approach to drug policy:
 » In California, while still the San Francisco District Attorney, George Gascón co-
authored Proposition 47.24 That ballot measure re-classified simple drug possession 
felonies as misdemeanors.
 » In Oregon, three elected prosecutors publicly supported a ballot measure that 
passed and took effect in February 2021.25 The law decriminalizes possession of 
small amounts of certain drugs by reclassifying these as civil cases.26 People can no 
longer be arrested or criminally prosecuted for possessing very small amounts of 
drugs including heroin, cocaine, and methamphetamine.27  
 » In Rhode Island, the state Attorney General voiced his support for a newly passed 
bill reclassifying possession of 10 grams or less of certain controlled substances 
from a felony to a misdemeanor.28  
 » In Chittenden County, Vermont, State’s Attorney Sarah George has supported 
decriminalizing personal drug use and possession.29 Her office stopped prosecuting 
misdemeanor possession of buprenorphine (which is used to treat opioid use 
disorder) in 2018.30 In 2021, Vermont became the first state to decriminalize 
possession of buprenorphine.31  
D. Support Existing Pre-Arrest or Pre-Booking Programs
Prosecutors can also promote public health and reduce the footprint of the criminal system 
by supporting pre-arrest programs. These programs are designed to prevent, minimize, or 
divert contact with the criminal system and offer access to housing, health care, and drug 
treatment to address underlying needs. Preventing people with substance use disorder 
from going to jail serves as a vital overdose prevention strategy. Individuals confronting 
substance use-related challenges are particularly vulnerable while incarcerated. The 
number of people who have died of drug overdoses has increased within state prisons 
22 State-by-State Laws, Drug Pol’y Alliance (last visited July 20, 2021). 
23 Id.
24 Cara Bayles, George Gascón on Being LA’s New Progressive Prosecutor, Law 360 (Dec. 6, 2020). 
25 Garrett Andrews, District Attorneys Disagree on Measure to Decriminalize Some Drugs, Bulletin (Oct. 14, 2020). 
26 Tatiana Parafiniuk-Talesnick, Starting Monday, Oregon Spearheading Drug Decriminalization: Here’s What You 
Need to Know, Register Guard (Jan. 31, 2021).  
27 Id. 
28 Katie Mulvaney, Drug Bills Signal Sea Change in RI’s Approach to Opioid Crisis, Providence J. (July 3, 2021). 
29 Karen Anderson & Mitch Wertlieb, “A  Public  Health Issue”: Chittenden Co. State’s Attorney on Drug 
Decriminalization, VT Pub. Radio (Feb. 23, 2021). 
30 Mike Riggs, This Vermont Prosecutor Is Pushing Back Against the DOJ’s Drug Warriors, Reason (June 15, 2018). 
31 Vermont Becomes First State to Legalize Limited Possession of Buprenorphine, VT Digger (June 3, 2021). 
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and jails in recent years.32  Unfortunately, most correctional systems do not provide people 
with evidence-based treatments, such as initiation or continuation of MOUD or access to 
naloxone.33
At the same time, people who are unable to gain access to drugs while incarcerated often 
go through an inhumane detoxification experience while in jail and remain abstinent 
until they are released. Research shows that people released from jail or prison have an 
elevated risk of overdose during the initial days and weeks after their release “probably 
due to decreased tolerance during incarceration.”34 
Seattle’s Law Enforcement Assisted Diversion (LEAD) program aims to stabilize court-
involved individuals struggling with poverty and severe behavioral health issues by 
conducting outreach to them and introducing them to case management, housing, and 
treatment services.  Outreach workers and case managers engage in trauma-informed care 
and establish a connection with participants to support long-term changes in their lives. 
LEAD prosecutors coordinate with case managers, law enforcement, and other community 
partners to help LEAD participants address their court obligations and navigate the legal 
system.
Although Seattle’s LEAD program is perhaps the most well-known diversion program in the 
country and has been replicated in many jurisdictions, there are other models anchored in 
harm reduction principles. For example, the District Attorney’s Office in Kings County, New 
York launched a program called Brooklyn Collaborative Legal Engagement Assistance 
Response (CLEAR). The program redirects people charged with low-level drug offenses 
to community-based treatment services as an alternative to prosecution. A peer mentor 
meets the person in custody at the precinct, gives them an overdose response kit with 
naloxone, and teaches them how to use it. The peer mentors are people in recovery with 
32 U.S. Dept. of Just., Bureau of Just. Stat., Mortality in Local Jails 2000-2018—Statistical Tables 1 (April, 2021) (“The 
number of deaths in local jails due to drug or alcohol intoxication has more than quadrupled between 2000 (37) 
and 2018 (178).”).      
33 See Christine Vestal, New Momentum for Addiction Treatment Behind Bars, Pew Charitable Trusts (April 4, 2018) 
(“In fact, nearly all corrections officials reject the use of either methadone or buprenorphine behind prison walls. 
That’s despite a history of research showing both medicines are highly effective at eliminating cravings, preventing 
overdoses and keeping people in recovery from opioid addiction.”). 
34 See Shannon Mace, et al., Medication-Assisted Treatment for Opioid Use Disorder in Jails and Prisons: A Planning 
& Implementation Toolkit, Vital Strategies & Nat’l Council for Behavioral Health 72 (2020) (“Individuals released 
from jail and prison are at heightened risk of opioid overdose, particularly in the first two weeks after release.” 
(citations omitted)). 
Click here for a short video presentation featuring a former 
LEAD prosecutor, Grace Wiener Ritter.
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lived experiences with substance use disorder. The CLEAR program requires participants 
to visit a community-based center soon after their arrest, where a case manager will 
recommend services – such as treatment, employment or housing – based on what the 
person says they need. If the person engages in services, the person does not have to go 
to court. Instead, the District Attorney’s Office dismisses the charge and the arrest is sealed. 
Click here for a short video presentation by Jose Ramos, one 
of Brooklyn CLEAR’s case managers, and Karen Varriale, the 
Brooklyn prosecutor who runs the program. 
E. Engage with Communities in Developing Pre-Arrest Diversion Programs
Elected prosecutors should acknowledge the profound harms of aggressive prosecution 
of drug offenses. They should maximize access to media to express a commitment 
to listening to people and communities whose entanglement in the criminal system is 
connected to drugs. Furthermore, prosecutors should commit to monitoring diversion 
programs to ensure that a person’s race or socioeconomic status does not determine 
whether they are given the opportunity to participate, and that there are not inequities in 
access to services and case outcomes.
Before an elected prosecutor implements any program, community members should have 
the opportunity to voice possible solutions. This process might start with town halls to 
learn from community members about how the enforcement of drug laws has affected 
their lives and perceptions of safety in their neighborhoods. Such events must be carefully 
planned with guidance from trusted organizations with credibility among drug users and 
other marginalized communities.
As an example of an initiative that prosecutors could support going forward, a coalition of 
marginalized groups launched Atlanta’s Policing Alternatives and Diversion Initiative (PAD) 
in 2017. The initiative was in response to broken-windows style policing that produced 
continuous cycles of arrest and incarceration among sex workers, people who use drugs, 
and unhoused people in downtown Atlanta. Through the initiative, the community now 
has the option to call 311 for a community caseworker to arrive on scene for a quality of 
life concern, instead of the police.
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III. Decision of Whether to Prosecute and What to Charge 
One of the greatest powers of a prosecutor is the ability to decide whether to move forward 
with a case and what to charge. Below are several ideas for prosecutors to consider — many 
with examples from jurisdictions adopting these principles — to reduce the negative impact of 
the criminal system on our communities’ public health.
A. Declining to Prosecute Cases
Elected prosecutors must reduce overreliance on the criminal system for public health 
problems by declining to prosecute certain cases. They should carefully assess cases 
brought to their offices by law enforcement because declining to prosecute certain cases 
can discourage the police from making certain arrests. Prosecutors should consider whether 
the prosecution of drug possession is necessary for community safety. If prosecutors do 
decline to prosecute entire categories of crime, such as simple drug possession, they 
should also advocate for the elimination of outstanding warrants connected to those 
crimes and decline to pursue probation violations for those offenses. 
For example, in March 2020, the Baltimore City State’s Attorney’s Office announced that 
it would no longer pursue drug possession, attempted distribution, and paraphernalia 
charges, among other crimes.35 The policy aimed to eliminate the use of arbitrary drug 
amounts that deem a crime “possession” with the understanding that users are varied 
in their drug consumption. The Baltimore City State’s Attorney’s Office also wanted to 
avoid signaling to drug sellers that there was a cut off that they could possess without 
being charged for distribution.36 The Office continues to charge possession with intent to 
distribute for drug selling, which requires indicia of sale like large amounts of cash, scales, 
bags, and individually wrapped products.  
The Baltimore City State’s Attorney’s Office found that prohibiting the prosecution of drug 
crimes had consequences for diversion programs because some programs required a 
drug possession charge for eligibility. As a result, the Office focused on increasing the 
types of offenses that would permit entry into diversion and reducing the barriers to entry, 
like criminal records. The Office began to consider crimes adjacent to drug use — theft and 
robbery, for example — and offer diversion to drug users charged with those crimes. The 
Office dismissed all pending possession cases, including drug possession crimes charged 
in cases with violent crimes. 
The Baltimore City State’s Attorney’s Office took additional steps to harmonize the policy.  
The office moved to dismiss all outstanding warrants for drug possession, including some 
decades-old cases. The Office decided not to move forward with any probation violation 
35 Tim Prudente, Confused over Marilyn Mosby’s New Policy on Baltimore Drug Prosecutions? Here’s What Her Office 
Says It Means, Balt. Sun (Apr. 26, 2021). 
36 Id. 
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charges where the underlying offense was drug possession. The Office coordinated with 
the police department, prompting the police department to announce that it would reduce 
arrests. According to a representative of the Baltimore City State’s Attorney’s Office, the 
city saw an 80 percent reduction in drug possession arrests and a 39 percent reduction 
in people entering the system. The city also saw a 33 percent reduction in 911 calls made 
about drugs.37  According to a press release from the Office, of the “nearly 1,500 individuals 
with quashed warrants or dismissed charges, only 0.4% (5 individuals) were arrested for 
any other crime during the 8-month period following the policy change.”38 
B. Bail
In the United States, a significant number of people who are incarcerated pretrial are 
detained simply because they cannot afford bail.39 There is a strong public health rationale 
for ending or strictly limiting reliance on cash bail. Imposing cash bail can result in people 
being subjected to jail conditions that imperil their health. Unfortunately, most jails are 
inhumane environments that lack the capacity to provide ethical detoxification and 
treatment options for people experiencing withdrawal, though that is slowly beginning to 
change.40 This problem results in the preventable suffering and deaths of people in jails as 
well as costly litigation for local jurisdictions.41 A person who is detained in jail also has an 
increased chance of suffering a fatal overdose upon release from custody.42  
Pre-trial detention, even for a short duration, can also trigger a host of deleterious 
consequences, including unemployment, loss of temporary or transitional housing, and 
37 Press Release, Office of the State’s Attorney for Baltimore City, State’s Attorney, Mayor’s Office, and Community 
Partners Announce Success of Covid Criminal Justice Policies (Mar. 26, 2021). 
38 Id. 
39  Bernadette Rabury & Daniel Kopf, Detaining the Poor, Prison Pol’y Initiative 1 (May 2016). 
40 Christine Vestal, This State Has Figured Out How to Treat Drug-Addicted Inmates, Pew Charitable Trusts (Feb. 26, 
2020). 
41 See Susan Pollitt, & Luke Woollard, Barriers to Access and Inadequate Levels of Care in North Carolina Jails, 80 
NC Med. J. No. 6, 345-346 (2019) (“However, in recent years lack of resources and increasing health care demands 
and costs have led to inadequate levels of care in North Carolina jails.”); J. Lyons, The Systematic Neglect of Inmates 
Suffering from Substance-Use Disorder in the American Prison Systems, 31 BYU Prelaw Rev. Art. 7 (2017) (discussing 
the inhumane treatment of several incarcerated individuals experiencing withdrawal); Bernie O’Donnell, Wilkinson 
County to Pay $420,000 Settlement in Woman’s Jail Death, 13WMAZ, Jan. 2, 2020; Elise Kaplan, Lawsuit Filed in 
Death of Inmate at Bernalillo County Metropolitan Detention Center, Albuquerque J. (July 23, 2021).  
42 See, e.g., Lia N. Pizzicato et al., Beyond the Walls: Risk Factors for Overdose Mortality Following Release from 
the Philadelphia Department of Prisons, 189 Drug and Alcohol Dependence, 108 (2018) (“Individuals released 
from incarceration [in a Philadelphia jail] had higher risk of overdose death compared to the non-incarcerated 
population.”). 
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other harms.43 Studies show that people detained pre-trial are significantly more likely to 
receive a prison sentence than those who are released pending disposition.44 As discussed 
throughout this Guide, imprisonment only exacerbates the likelihood that someone with 
substance use disorder will suffer from the aforementioned harms.
There are a several ways prosecutors can reduce the effects of cash bail in their local 
systems to promote public health. First, incumbent district attorneys and those seeking 
election can advocate for ending the use of cash bail in their local court systems. A growing 
number of prosecutors, in states such as California, Vermont, and Michigan, are calling for 
reduced reliance on cash bail.45 The reasons outlined above may help persuade voters, 
judges, and other constituents to embrace these changes. 
In addition, while prosecutors do not set bail, they have significant influence over whether 
bail is imposed and at what amount. Prosecutors in leadership positions can instruct their 
line prosecutors not to pursue pre-trial detention and monetary bail for designated drug 
charges (for example, possession and small sales), sex work, public intoxication, and other 
quality-of-life crimes.
C. Mandatory Minimum Sentences
Prosecutors routinely charge people with crimes carrying a mandatory prison sentence, 
and then offer a plea to a lesser crime that carries a significantly lower penalty. This 
practice can put the accused under a tremendous amount of pressure.46 In addition to 
severe punishments for drug-related crimes, mandatory minimums have fueled mass 
incarceration.47 Therefore, prosecutors should implement clear written policies as to when 
line prosecutors can charge crimes that carry mandatory prison sentences. For instance, 
prosecutors should consider prohibiting such a charge when it is a person’s first or second 
offense. 
Prosecutors must be aware of the consequences of charging certain offenses and think 
more holistically about their use of mandatory sentencing structures. Prosecutors should 
43 See Will Dobbie et al., The Effects of Pretrial Detention on Conviction, Future Crime, and Employment: Evidence 
from Randomly Assigned Judges, 108 Am. Econ. Rev. 201, 204 (2018) (“We find evidence that pretrial release 
increases both formal sector employment and the receipt of employment- and tax-related government benefits, 
with larger effects among individuals with no prior offenses in the past year.”); Emily Leslie & Nolan G. Pope, The 
Unintended Impact of Pretrial Detention on Case Outcomes: Evidence from New York City Arraignments, 60 J. of L. 
and Econ. 529, 530 (2017) (“Detainees might miss work and therefore forgo income or even lose employment, and 
they are unable to attend to family responsibilities or access their social support network.”). 
44 See Christopher T. Lowenkamp et al., Investigating the Impact of Pretrial Detention on Sentencing Outcomes, 
Arnold Ventures 4 (2013) (“Low-risk defendants who are detained for the entire pretrial period are 5.41 times more 
likely to be sentenced to jail and 3.76 times more likely to be sentenced to prison when compared to low-risk 
defendants who are released at some point before trial or case disposition. Moderate and high-risk defendants 
who are detained for the entire pretrial period are approximately 3 times more likely to be incarcerated than similar 
defendants who are released at some point.”). 
45 Rachel M. Cohen, Newly Elected Michigan Prosecutor Will Stop Seeking Cash Bail, Appeal, Jan. 4, 2021. 
46 Michael Cassidy, (Ad)ministering Justice: A Prosecutor’s Ethical Duty to Support Sentencing Reform, 45 Loy. U. 
Chi. L.J. 981, 999-1000 (2014). 
47 Id. at 987-88. 
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make sure that the consequence of such a charge fits the situation they are prosecuting. 
This means conducting a comprehensive investigation of a case before presenting it to a 
grand jury to understand not only the crime, but also the person charged. For example, 
with regard to hand-to-hand drug sellers, prosecutors should consider the circumstances 
of sellers who live in extreme poverty. 
Mandatory minimum statutes have been shown to perpetuate racial disparities.48 Elected 
prosecutors should make sure their attorneys are aware of the bias that has resulted in the 
disproportionate application of these statutes and should implement policies to actively 
combat racial disparities in sentencing. A prosecutor’s written policy should ensure that 
their office is monitoring charges and sentencing recommendations for racial disparities. 
Closely related to the use of mandatory minimums are habitual offender statutes, which 
increase a person’s exposure to prison time when they have a prior conviction. Particularly 
because long prison sentences have been found ineffective in addressing drug-related 
crimes, prosecutors should avoid utilizing habitual offender statutes when possible. 
In Ingham County, Michigan, the District Attorney’s Office requires line prosecutors to 
consider, among other things, the age of the prior conviction and whether the person has 
a history of violence before using a habitual offender statute.   
D. Drug Induced Homicide    
A Growing Trend 
A steep and steady surge in overdose-related fatalities across the United States has 
sparked a series of legislative responses. Some states have passed Good Samaritan laws, 
which provide varying degrees of criminal immunity for people who witness or experience 
an overdose and call 911 for medical assistance. At the same time, however, states have 
enacted statutes that allow for the prosecution of people who distribute drugs that are 
linked to a fatal overdose. 49 
The legal constructs and penalties in these statutes – often referred to as drug-induced 
48 Sonja B. Starr & M. Marit Rehavi, Mandatory Sentencing and Racial Disparity: Assessing the Role of Prosecutors 
and the Effects of Booker, 123 Yale L.J. 2, 7 (2013) (“But judges’ choices do not appear to be principally responsible. 
Instead, between half and the entire gap can be explained by the prosecutor’s initial charging decision -- specifically, 
the decision to bring a charge carrying a ‘mandatory minimum.’ After controlling for pre-charge case characteristics, 
prosecutors in our sample were nearly twice as likely to bring such a charge against black defendants.”). 
49 See generally, Leo Beletsky, America’s Favorite Antidote: Drug-Induced Homicide in the Age of the Overdose 
Crisis, 2019 Utah L. Rev. 833 app. (2019). 
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homicide (DIH) laws or “drug delivery resulting in death” statutes – vary in specificity and 
severity. DIH statutes originated as part of the “War on Drugs” that contributed to mass 
incarceration and the disproportionate prosecution of people of color. The same 1986 
federal drug law that made a significant distinction in sentencing between crack cocaine 
and powder cocaine50 also mandated a sentence of 20 years to life for drug-induced 
homicide.51 As of 2019, twenty-five states have enacted some form of a DIH statute.52  Over 
a dozen carry minimum prison sentences, including several that impose life sentences or 
the death penalty.53  Some DIH statutes are broad and can apply to someone who merely 
delivers or administers a drug that results in a fatal overdose.54  
The criminalization of drug distribution places a responsibility on prosecutors to act in 
many tragic situations where a fatal overdose occurs, family members are grieving, and 
an investigation by law enforcement reveals who supplied, sold, or administered a drug 
that led to a fatal overdose. In these cases, prosecutors are under tremendous pressure to 
act. As a result, prosecutors have increasingly relied on the prosecution of DIH in response 
to the overdose crisis.55 Unfortunately, many district attorneys and line prosecutors are 
not well-versed in how their charging decisions and public messaging may counteract 
the efforts of public health agencies and other stakeholders on the frontlines of overdose 
prevention initiatives. For example, one purported justification of DIH enforcement is to 
deter the distribution of illicit drugs on the streets, particularly those that carry a high-
risk of overdose, such as heroin. However, critics argue that DIH laws and their highly-
publicized enforcement are generally more likely to worsen the underlying problems that 
they purport to address.56  Therefore, notwithstanding the pressure prosecutors may face 
to pursue drug-induced homicides, prosecutors must consider the potential ramifications 
of these cases and the long-term consequences of prosecuting them.
One of the biggest concerns about prosecuting drug-induced homicides is that these 
prosecutions undermine Good Samaritan laws. The primary goal of Good Samaritan 
laws is to save lives by encouraging people most likely to witness an overdose to call for 
50 Sarah N. Lynch, U.S. Justice Department Backs Bill To End Disparities in Crack Cocaine Sentences, Reuters (June 
22, 2021) (“In 1986, Congress passed a law to establish mandatory minimum sentences for drug trafficking offenses, 
which treated crack and cocaine powder offenses using a 100 to 1 ratio. Under that formula, a person convicted for 
selling 5 grams of crack cocaine was treated the same as someone who sold 500 grams of powder cocaine.”). 
51 21 U.S.C.A. § 841; Jake Shuler, Overdose and Punishment, New Republic (Sept. 10, 2018). 
52 See Drug Induced Homicide Laws, Prescription Drug Abuse Pol’y Sys. (Jan. 1, 2019). 
53 Id. 
54 For example, in Michigan, “[a] person who delivers a schedule 1 or 2 controlled substance, other than marihuana, 
to another person . . . that is consumed by that person or any other person and that causes the death of that person 
or other person is guilty of a felony punishable by imprisonment for life or any term of years.” MICH. COMP. LAWS 
§ 750.317a (West 2018).
55 In Pennsylvania, for example, “[d]rug delivery resulting in death charges statewide . . .  increased by 1,267 percent 
between 2013 and 2017.” Drug Delivery Resulting in Death Citations at Five-Year High, Unified Jud. Sys. PA. (Mar. 9, 
2018). 
56 Kelly Kung et al., Analysis of the Effect of Drug Induced Homicide Prosecution Media Reports on Drug Overdose 
Deaths (forthcoming 2021) (“We estimate that an increase in media coverage of DIH prosecutions is associated 
with an approximately 7.7% increase in overdose deaths.”); Beletsky, supra note 49, at 875-80 (explaining why DIH 
laws do not fulfill their purported purposes of deterrence, incapacitation, and retribution). 
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emergency help.  In most situations, the people in the best position to call for emergency 
medical intervention are friends, family members, and social acquaintances who are 
also using or supplying the drugs before someone with them overdoses. Mitigating the 
fear of arrest and prosecution when timely medical intervention is necessary increases 
the likelihood that people call 911.57 Good Samaritan laws are based on the theory that 
people who use drugs are more likely to seek help when fear of police, prosecutors, and 
legal penalties is diminished.58  
DIH laws are antithetical to Good Samaritan laws. The vast majority of Good Samaritan 
statutes only apply to possession charges, and not to distribution or death resulting from 
overdose.59 Therefore, in jurisdictions with DIH laws, individuals involved in any form 
of distribution (even at the lowest level) may decline to call for medical attention when 
someone in their presence overdoses notwithstanding the existence of a Good Samaritan 
law.60  
A Point of Disagreement in the Working Group: Whether Prosecutors Should Ever Prosecute DIH 
Cases
The working group spent a significant amount of time discussing DIH laws and whether 
enforcement of those laws is ever appropriate. There was consensus among group members 
that these laws have been exploited in reaction to the overdose epidemic and that they 
have resulted in the unjust prosecution of family members and friends who struggle with 
substance use disorder. Additionally, as detailed above, the working group agreed that 
DIH prosecutions undermine Good Samaritan laws and may lead to dangerous responses 
to drug overdoses. 
However, there was disagreement on the ultimate question of whether DIH prosecutions 
were ever appropriate. Some group members felt all DIH prosecutions are irreconcilable 
57 See An Overdose Death Is Not Murder: Why Drug-Induced Homicide Laws Are Counterproductive and Inhumane, 
Drug Pol’y Alliance 40 (2017) (citing studies that show fear of police involvement is a common reason people do 
not call 911 when witnessing an overdose). 
58 Caleb J. Banta-Green et al., Univ. of Wash. Alcohol & Drug Abuse Inst., Washington’s 911 Good Samaritan Drug 
Overdose Law: Initial Evaluation Results (Nov. 2011) (“88% of opiate users indicated that now that they were aware 
of the law they would be more likely to call 911 during future overdoses.”); Andrea Jakubowski et al., Knowledge 
of 911 Good Samaritan Law and 911-Calling Behavior of Overdose Witnesses, Substance Abuse (Oct. 3, 2017) (“In 
the overdose events where the participant had correct knowledge of the GSL [Good Samaritan Law] at the time of 
the event, the odds of a bystander calling 911 were over three times greater than when the witness had incorrect 
knowledge of the GSL . . . .”).
59 Jeremiah Goulka et al., Drug-Induced Homicide Defense Toolkit 63 (Ohio State Pub. L. Working Paper No. 467 63, 
2021) (“Unfortunately, Good Samaritan laws are too narrowly drawn. In every state except Vermont and Delaware, 
these laws only provide immunity to charges for possession of drugs and drug paraphernalia for personal use, 
not to distribution or death resulting from overdose—and these laws vary state to state on whether they cover 
investigation, arrest, and/or prosecution. In other words, they create a quandary for people calling 911: you 
(probably) won’t get in trouble if the person experiencing an accidental overdose event survives, but if death 
occurs, you’re calling the cops on yourself.”). 
60 There is also growing concern that the enforcement of DIH laws may perpetuate racial disparities. Although the 
data is very limited, a recent study that compiled media reports of DIH cases from 2000 to 2017 found that half of 
the 86 cases involved a situation where the deceased person was white, and the accused was a person of color. See 
Beletsky, supra note 49, at 889. 
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Drug courts have proliferated across the nation, and there is good reason to believe that they 
will remain prevalent in the criminal system for the foreseeable future. Of course, drug courts 
vary in their structure, eligibility criteria, treatment options, and typical program requirements 
for participants. In recent years, drug courts have been critiqued by researchers, clinicians, and 
harm reduction experts because many of their practices are overly burdensome, punitive, and 
not aligned with principles of harm reduction and evidence-based medicine. In jurisdictions 
where drug courts are a well-established component of the judicial system, prosecutors 
should be aware of common pitfalls of drug courts and make strides to ensure that drug courts 
incorporate best practices in harm reduction and public health.
The literature on pitfalls of drug courts is extensive. Fair and Just Prosecution outlines the 
common issues and critiques of drug courts for prosecutors in a detailed issue brief.61 That 
document explains, for example, that many drug courts use a “stigmatizing abstinence-based 
definition of recovery,” are not clinically sound, do not adequately serve those most in need of 
treatment, and exacerbate racial disparities. Rather than repeating these critiques, which have 
been researched and written about at length, the authors encourage prosecutors to refer to the 
attached Appendix for more resources.
61 Reconciling Drug Courts, Decarceration, and Harm Reduction, Fair and Just Prosecution (2021). 
with principles of public health and should never be charged. Others opposed an 
inflexible policy prohibiting all DIH prosecutions because of the possibility of unforeseen, 
unique circumstances. Ultimately, however, the working group was unanimous that DIH 
prosecutions will not end the overdose crisis and should rarely – if ever – be pursued. 
Prosecutors have an opportunity to prioritize innovative, evidence-based solutions that 
address systemic factors rather than relying heavily on punitive tactics, such as DIH 
enforcement, that fail to address the core issues.
IV. Drug Courts
Click here for short video presentations by Tele Rabii and 
Julie Eldred about their personal experiences with drug 
court.
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V. Plea Negotiations
A. Prioritize Cases in Which the Accused Presents a Genuine Safety Threat
Ideally, prosecutors would decline to pursue cases that are not appropriate for the criminal 
system before they even charge the accused. For instance, prosecutors would distinguish 
those who sell drugs to support their own use from those who are selling enormous 
amounts of drugs for pure financial gain at the charging stage, and decline to prosecute 
the former category of cases. Realistically, however, prosecutors need time and resources 
to determine who presents a true public safety threat. Therefore, a prosecutor’s efforts to 
approach drug cases in an innovative way will likely take place after charging and during 
plea negotiations. It will involve rigorous investigation to determine the motivation for the 
crime and the potential for recidivism.
Prosecutors should consider several factors when deciding whether a case should be given 
a non-incarceratory disposition. First, prosecutors should not pursue punitive sentences 
for people who are engaged in the sale of drugs when the accused’s motive is clearly 
to support a substance use disorder. Studies show that a significant number of people 
charged with distribution-related crimes also use drugs.62 Given that jails and prisons are 
ill-equipped to address substance use disorder, prosecutors should generally divert these 
cases into treatment and other supportive programs, or ultimately dismiss them. 
Second, even for people who are engaged in distribution solely for economic reasons (and 
not because of substance use disorder), prosecutors should scrutinize which distribution 
cases they are prosecuting, and to what end. Although prosecutors routinely justify the 
prosecution of distributors on the ground that distributors prey on vulnerable people, the 
prosecution of low-level dealers has proved ineffective in stopping drug use, in large part 
because low-level dealers are easily replaced with new ones.63 In addition, prosecutors 
often justify pursuing cases against low-level distributors as a means to prosecute those 
at higher levels in criminal enterprises. However, in reality, the vast majority of people 
incarcerated for drug distribution offenses are those at the lowest levels of an organization.64  
62 Rethinking the Drug Dealer, Drug Pol’y Alliance 36 (2019) (“A 2004 Bureau of Justice Statistics report found that 
70% of people incarcerated for drug trafficking in state prison reported that they had used drugs in the month prior 
to their offense. A 2017 report by the same agency found that 29.9% of people in state prison and 28.8% of people 
sentenced to jail for drug offenses between 2007 and 2009 said their offense was committed to acquire drugs or to 
get money for drugs. In 2012, 84% of those arrested for distribution offenses in Chicago, 92.9% in New York, 87.8% 
in Sacramento, and 38.1% in Washington, D.C. tested positive for drug use.”) (citations omitted)). 
63 Id. at 12; Federal Drug Sentencing Laws Bring High Cost, Low Return, Pew Charitable Trusts (2015) (“Even if 
street-level drug dealers are apprehended and incarcerated, such offenders are easily replaced, ensuring that drug 
trafficking can continue, researchers say” (citations omitted)). 
64 Ryan S. King & Marc Mauer, Distorted Priorities: Drug Offenders in State Prisons, Sent’g Project 7 (Sept. 2002) 
(“Using this framework, we can identify an upper limit of 28.5% of the drug offenders who reported a level of 
activity that might constitute a high-level role in the drug economy . . . . this total should be viewed as an upper 
limit and we can assume that the overall proportion is actually lower. Therefore, a significant proportion of drug 
offenders in prison – at least 71% -- reported no involvement in actions that could be considered ‘high-level drug 
activities.’”); U.S. Sent’g Comm’n, Mandatory Minimum Penalties for Drug Offenses in the Federal Criminal Justice 
System 43-45 (Oct. 2017) (showing that less than a quarter of those convicted in 2016 in the federal system were 
categorized as an “importer/high-level supplier,” “organizer/leader” or “grower/manufacturer” rather than a lower-
level member of the organization). 
21A New Approach: A Prosecutor’s Guide to Advancing a Public Health Response to Drug Use
The fact that so few incarcerated distributors are leaders of large criminal enterprises 
indicates our system is prioritizing the prosecution of low-level dealers. At a minimum, 
elected prosecutors should evaluate how often they are sending low-level distributors 
to jail or prison, at what level in an organization those people are operating, and what 
percentage of those prosecutions led to the successful prosecution of a major supplier. If 
few of the prosecuted distribution cases are leading to successful prosecutions of major 
drug suppliers who perpetuate violence in their communities, then the office should shift 
resources to prosecuting crimes that have a bigger impact on public safety (for example, 
distributing drugs while possessing a loaded firearm). 
Third, even when prosecutors use low-level dealers to pursue high-level suppliers, they 
must take into account the harms inflicted on low-level sellers as the office pursues the 
“kingpin” of an operation. The literature on collateral consequences of a conviction and 
incarceration makes clear that those who serve time in prison suffer major barriers to 
employment, education, housing, and a myriad of other aspects of life.65 The ultimate 
question prosecutors should ask themselves when pursuing low-level distributors is, 
“What is the good that will come from this prosecution, and what is the harm?” In other 
words, before prosecuting a low-level seller as a means to pursue a high-level supplier, 
prosecutors must engage in a cost-benefit analysis. They should evaluate whether 
prosecuting and incarcerating the high-level supplier will have a big enough impact on 
public safety to justify the harm inflicted on low-level dealers.
B. Do Not Rely on Coercive Plea Tactics 
Prosecutors should avoid pressuring the accused to plead guilty early in a case to a high-
level charge contingent on various terms. Prosecutors traditionally have relied on such 
pleas to maximize their leverage so that the accused has a large “hammer” hanging 
over them in the event they do not satisfy the conditions of the plea (whether the terms 
include probation, treatment, or the completion of drug court). However, such early pleas 
are unduly coercive. Instead, prosecutors should, for example, adjourn the case for six 
months to see whether the person engages in treatment or another program and consider 
dismissing the case if the accused shows significant progress in that program. By simply 
adjourning the case, prosecutors reduce the level of coercion while retaining some degree 
of leverage because they can ultimately still move forward with prosecution. Moreover, 
during the pendency of the case, the accused is not saddled with a criminal conviction. 
C. Prioritize Investigations to Make Fair Plea Decisions, and Consider the Accused’s Personal 
Circumstances
During plea negotiations, prosecutors should gather as much information about the accused 
as possible, including family history, substance use history, mental health information, and 
the underlying facts of prior convictions. Conducting an investigation into the history of the 
65 For a comprehensive review of the collateral consequences of criminal convictions, see Collateral Consequences: 
The Crossroads of Punishment, Redemption, and the Effects on Communities, U.S. Comm’n on Civil Rights (June 
2019). 
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accused gives a prosecutor a more complete picture of their circumstances, which can lead 
to a more just plea offer and outcome. Prosecutors should remember that defense counsel 
may be allies in conducting such investigations and should encourage defense attorneys to 
provide as much information about their clients as possible.
Prosecutors must be aware that individuals selling drugs in the absence of a substance use 
disorder may be facing poverty, lack of opportunity, and intergenerational trauma, which 
should be considered when evaluating the merits of a case. Drug distribution is a crime of 
opportunity often sought out by marginalized individuals. Through drug distribution, an 
individual may gain a level of respect and self-confidence that traditional institutions have 
failed to provide. 
Studies have shown that the majority of incarcerated people serving a sentence related to 
drug offenses are not violent.66 Therefore, prosecutors should not assume that imposing 
long prison sentences on drug sellers will remove perpetrators of violence off the street. 
Furthermore, prosecutors should consider that prison can often be traumatizing and 
dehumanizing, leading to worse, not better, outcomes for individuals subjected to it.67 
Prosecutors should also consider the accused’s circumstances in drug-related cases that 
include charges beyond possession and sale, such as drug-related sex work, burglaries, 
larcenies, and robberies. While the accused’s motive is rarely a legal element required to 
prove a charge, prosecutors should consider motive during plea negotiations. Prosecutors 
should ask hard questions, interview witnesses, seek information about the accused, and 
attempt to understand why a crime was committed. For instance, in a case involving the 
burglary of the lobby of a building that does not result in physical harm and appears 
motivated by the need to support a substance use disorder, the prosecutor should try to 
gather information about the accused’s background and make a non-incarceratory plea 
offer. 
66 King & Mauer, supra note 64, at 4 (“[A]pproximately three-quarters of inmates currently serving a sentence for a 
drug offense have no current or prior convictions for a violent offense, and more than a third of the total have been 
convicted only of drug offenses.”). 
67 Danielle Sered, Accounting for Violence: How to Increase Safety and Break Our Failed Reliance on Mass 
Incarceration, Vera Inst. of Just. 23 (2017) (“Studies demonstrate that prison can have a criminogenic effect — 
meaning it is likely to cause, rather than prevent, further crime.”). 
Click here for a short video presentation by Andre Ward, 
who was incarcerated for a drug trafficking-related crime.
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VI. An Alternative to Traditional Drug Prosecution
Some people commit felonies such as burglary, robbery, and grand larceny to buy drugs to 
alleviate tormenting symptoms of withdrawal.  Prosecutors may be inclined to request high 
amounts of bail and be less willing to consider diversion programs in such cases, especially when 
there is a victim who was harmed by the conduct of the accused. Despite these challenges, there 
are a variety of ways prosecutors can consider the clinical needs and life circumstances of the 
accused while also holding them accountable for their behavior. For instance, prosecutors can 
create restorative justice programs for people who commit more serious drug-related felonies 
such as sale or even those involving violence. Restorative justice is a promising movement 
that delivers accountability for harms but also promotes a process of healing for the person 
who caused the harm. Common Justice, an organization located in New York City, provides 
restorative justice programs for young adults charged with serious felonies. These programs 
can rectify harms and promote community safety, while also avoiding the harms that traditional 
prosecution can perpetuate.
The federal RISE program in the District of Massachusetts uses restorative justice principles 
and is in part specifically designed for people whose history of substance use disorder 
substantially contributed to the commission of the crime charged.68 In RISE workshops, 
participants, community members, and surrogate victims (i.e. people who have lost children 
to drug overdoses) meet to help RISE participants “appreciate that their crimes harmed real 
people, that they too may have been harmed by their crimes or other circumstances in their 
life, and that they bear an obligation to repair the harm they caused.”69 Unlike Common Justice, 
the RISE program includes cases that do not involve a specific victim, such as drug sales.70  
Another model for drug-related cases is the Community Diversion Program in King County, 
Washington. The Prosecuting Attorney’s Office is working with community, county, and criminal 
justice partners to launch a pre-filing diversion program by early 2022 that will allow eligible 
people facing their first felony to be assessed by a public health official and matched with a 
community partner for services and support (in lieu of having their case filed by the prosecutor’s 
office).71 In addition, the program will include a Victim Restoration Fund for harmed parties, 
which is designed to immediately reimburse victims for some of their financial losses. The 
program will eventually be fully funded through savings from reduced use of courts, jails, and 
legal services. Eligible cases include some property crimes and drug offenses, but not violent 
crimes.
68 Leo T. Sorokin & Jeffrey S. Stein, Restorative Federal Criminal Procedure, 119 Mich. L. Rev. 1315, 1334 (2021). 
69 Id. at 1335. 
70 Id. at 1337. 
71 Matt Markovich, King County Council OKs Plan To Let Community Groups Decide Some Punishment--Not Judges, 
KOMO News (Nov. 17, 2020). 




Prosecutors should review lengthy drug-related sentences and consider whether courts 
could be used retroactively to resentence those already incarcerated. To make the process 
easier, states have begun enacting legislation to allow prosecutors to re-sentence people who 
have been incarcerated far longer than necessary for drug-related crimes. Prosecutors can 
advocate for these changes in legislation. Further, prosecutors should advocate for legislation 
that expunges the criminal records of people convicted of drug crimes to alleviate barriers to 
employment and other significant, long-standing consequences of a criminal conviction.
Prosecutors must use their power and status within the criminal system to help end 
counterproductive and overly punitive practices in drug prosecution. With drug overdoses at an 
all-time high, prosecutors’ offices owe it to the communities they serve to advance drug policy 
grounded in principles of harm reduction, public health, and racial justice. Elected prosecutors 
can minimize and reshape their role in the drug epidemic by (1) ensuring line prosecutors have 
a basic understanding of substance use disorder; (2) using their status within the community 
to end the stigma surrounding drug use and advocate for more social services; (3) developing 
office policies and practices that reduce the negative impact of the criminal system on the 
community’s public health; (4) ensuring their local drug courts reflect the principles of harm 
reduction; and (5) supporting legislation that allows courts to re-sentence people who have 
been incarcerated far longer than necessary for drug-related crimes. Prosecutors should take 
advantage of their unique and powerful position within the criminal system to address the core 
issues of the nation’s drug epidemic.
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